Tuberculosis News and Research

Latest Tuberculosis News and Research

Differences in leading causes of disease burden between males and females

A recent study reveals that males bear a higher disease burden overall, while females experience a higher burden from seven specific conditions, emphasizing the need for tailored health interventions.

5 May 2024

Global research offers insights about health burden disparities between genders

Globally, there are substantial differences between females and males (aged 10 and older) when it comes to health, with limited progress in bridging these health gaps over the past 30 years, according to a new study examining the disparities in the 20 leading causes of disease burden between females and males, across ages and regions, published in The Lancet Public Health journal.

2 May 2024

WHO overturns dogma on airborne disease spread. The CDC might not act on it.

The World Health Organization has issued a report that transforms how the world understands respiratory infections like covid-19, influenza, and measles.

1 May 2024

Study rethinks immune system strategies to boost vaccine effectiveness

A recent Cell journal review explores key immunological assumptions to enhance our understanding of vaccine design, autoimmune responses, and immune system pathology, aiming to refine intervention strategies and theoretical frameworks in immunology.

28 Apr 2024

Harnessing immune enhancement to combat drug-resistant tuberculosis

Experts are working on novel immune-enhancing therapies called host-directed therapies to use the body's own immune system to target tuberculosis, with hopes that they could tackle even the drug-resistant forms of the disease.

26 Apr 2024

Revvity unveils a new era of automated tuberculosis testing

Revvity, Inc. (NYSE: RVTY) today announced the launch of the Auto-Pure 2400 liquid handler from Allsheng for use with the T-SPOT.TB test. The Auto-Pure 2400 platform is easy to use and designed to provide efficient workflows in the lab. When the accuracy of the T-SPOT.TB test is combined with the efficiency of the Auto-Pure 2400 system, labs, clinicians and ultimately patients, benefit from the resultant powerful solution.

From Revvity 26 Apr 2024

154 million lives saved: Landmark study highlights power of vaccination

A major landmark study to be published by The Lancet reveals that global immunization efforts have saved an estimated 154 million lives – or the equivalent of 6 lives every minute of every year – over the past 50 years.

25 Apr 2024

Owlstone Medical secures $6.5 million to support development of breath-based diagnostics for infectious disease

Funding represents the first time the foundation has taken an equity position in a breath diagnostics company.

From Owlstone Medical Ltd 25 Apr 2024

Undernourished household contacts three times more likely to develop TB

Mycobacterium tuberculosis, the bacteria that causes tuberculosis (TB), is distinct from most germs in its capacity to silently infect individuals for months and even years before waking up and causing active disease that can lead to severe illness and death.

23 Apr 2024

WHO publishes report introducing updated terminology for airborne pathogens

Following consultation with public health agencies and experts, the World Health Organization (WHO) publishes a global technical consultation report introducing updated terminology for pathogens that transmit through the air.

22 Apr 2024

UC Riverside nematologist receives NIH award to study parasite-host interactions

To study how parasites evolve to break the defenses of their hosts, the National Institutes of Health has granted UC Riverside nematologist Simon "Niels" Groen a $1.9 million Outstanding Investigator Award.

18 Apr 2024

The path to a better tuberculosis vaccine runs through Montana

A team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an infectious disease that has killed more people than any other.

18 Apr 2024

Global disease burden study highlights COVID-19 impact and health inequities

Rates of early death and poor health caused by HIV/AIDS and diarrhea have been cut in half since 2010, and the rate of disease burden caused by injuries has dropped by a quarter in the same time period, after accounting for differences in age and population size across countries, based on a new study published in The Lancet. The study measures the burden of disease in years lost to early death and poor health.

17 Apr 2024

Novel antibacterial discovery: Umbrella toxin particles secreted by Streptomyces

Researchers have discovered toxic protein particles, shaped like umbrellas, that soil bacteria known as Streptomyces secrete to squelch competitors, especially others of their own species.

17 Apr 2024

TAME trial findings offer new hope for children with malnutrition enteropathy

A comparison of treatments for malnutrition enteropathy, caused by severe acute malnutrition (SAM), has found evidence supporting the use of treatments to enhance the healing of mucosal membranes and reduce inflammation in the gut to improve the outcomes of children affected by long-term health consequences of a period of malnutrition.

17 Apr 2024

Study reveals lasting lung damage in tuberculosis survivors

New research being presented at this year's ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April) has found compelling evidence that tuberculosis (TB) can have a lasting impact on the lungs of individuals who have been successfully treated for the disease.

15 Apr 2024

Netherlands and WHO forge stronger partnership in global health agenda

The WHO and the Netherlands convened in The Hague on 10 April 2024, to discuss joint priorities and alignment between the Dutch Global Health Strategy and WHO's key strategic goals, marking a new milestone in their longstanding partnership.

15 Apr 2024

Rethinking the germ theory: A balanced take on microbes and disease outcomes

Review explores the complexities of infectious disease outcomes through a balanced perspective, emphasizing the interplay between pathogenic microbes and host conditions, challenging the traditional germ-disease theory by proposing a more integrated view that considers both pathogen virulence and host immunity's impact on disease manifestation.

10 Apr 2024